Stable Aqueous Weight Loss Composition with Synergistic Adrenergic Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current weight loss methods, including dietary supplements, often result in modest weight reduction with significant side effects, and do not effectively address long-term health issues related to obesity, such as diabetes and cardiovascular disease, while also lacking efficacy for individuals with normal or underweight classifications seeking improved physical performance and appearance.
Innovation Solution
A stable aqueous composition comprising biologically-active fat loss agents that stimulate beta adrenergic receptors and inhibit alpha adrenergic receptors, including yohimbine, 11-hydroxy yohimbine, methyl synephrine, and methyl tetradecylthioacetic acid, which work synergistically to enhance fat burning and weight loss without the harmful side effects of existing treatments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If dietary supplements are used for weight loss, then weight reduction is achieved, but side effects occur
Solution Approach 1:
The patent changes the chemical parameters of the supplement by using stabilized aqueous compositions with specific pH ranges (3-7) and temperature stability (4-40°C), which maintains bioactive species concentration and reduces degradation-related side effects while preserving weight loss efficacy
Solution Approach 2:
The patent combines multiple bioactive compounds (yohimbine, 11-hydroxy yohimbine, alpha-yohimbine, methyl synephrine, methyl PEA isomers, methyl hordenine, and methyl tetradecylthioacetic acid) into a composite formulation that works synergistically to enhance fat burning while reducing individual compound side effects
2Quantity of substance
If medication is used to reduce fat absorption, then weight reduction is achieved, but deleterious side effects occur
Solution Approach 1:
The patent uses naturally occurring compounds (yohimbine from bark, synephrine from citrus) that copy the body's natural catecholamine structure, allowing them to interact with adrenergic receptors in a physiologically compatible manner, thereby achieving weight loss without the harsh side effects of synthetic fat absorption blockers
3Use of energy by moving object
If metabolic stimulant supplements are used, then metabolism is increased, but harmful side effects occur
Solution Approach 1:
The patent segments the metabolic stimulation function across multiple compounds with different mechanisms: yohimbine and its isomers provide alpha-adrenergic blockade, methyl synephrine provides beta-adrenergic stimulation, and methyl tetradecylthioacetic acid provides additional metabolic support. This segmentation distributes the metabolic burden and reduces the side effects associated with single-compound high-dose stimulants
Solution Approach 2:
The patent stabilizes the metabolic stimulants in aqueous solution with controlled pH (3-7) and temperature (4-40°C) parameters, which prevents degradation and maintains consistent, lower effective doses that reduce side effects like high blood pressure, rapid heart rate, and insomnia while preserving the metabolic boosting effect
Data Source
AI summary
This invention provides unique and advantageous formulations and methods for weight loss.